TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: Schmidt Confers With Califano, Fredrickson On NCI director; Senate Hearing March 15-16 February 18, 1977